The SA Greenberg Lab: The Inclusion Body Myositis Research Project

Inclusion Body Myositis

Our Goal

Our inclusion body myositis research program is focused on achieving a full understanding of the mechanisms of this disease in order to devise rational approaches to therapy. Such approaches may include high-throughput drug discovery screens, which we are using for another inflammatory myopathy dermatomyositis, or other approaches that might be evident only after a fundamental understanding of this disease is achieved.

Our Inclusion Body Myositis Research Projects

We have ongoing research projects that broadly cross a large range of disease mechanisms for inclusion body myositis. Some of our projects make few initial assumptions as to the nature of the disease process (“observation-driven” rather than “hypothesis-driven” research), and others test existing hypotheses. We study both the immunology and the “degenerative” aspects of inclusion body myositis. Below, we discuss projects only for which results have been published in peer-reviewed journals or have been presented in abstracts at major scientific meetings. A number of other projects are ongoing and will be posted after portions of the research are presented in acceptable scientific formats.

Two projects have approached inclusion body myositis in an unbiased manner to examine the large-scale expression of molecules reflecting the activity of genes (gene expression: RNA) and function (proteins) in inclusion body myositis muscle tissue. These are:

Projects that are focused specifically on the nature of the immune response present in inclusion body myositis are:

Projects that are focused specifically on the nature of the “degenerative response” present in inclusion body myositis are:

© 2009 The Greenberg Lab. Data Release Policy
About Us | Research | Publications | Data | Resources